Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
16 hedge funds and large institutions have $2.01M invested in Acer Therapeutics Inc in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
11% less funds holding
Funds holding: 18 → 16 (-2)
13% less capital invested
Capital invested by funds: $2.31M → $2.01M (-$299K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$29.9K |
| 2 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$23.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.61K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$7.41K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$397 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$78.8K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$26K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$25K |
| 4 |
Goldman Sachs
New York
|
-$12K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$11.5K |
ACER Hedge Fund Activity: Q2 2014 in Review
16 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2014, worth a combined $2.01M — down 13% from $2.31M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ACER and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Shepherd Kaplan Krochuk, adding an estimated $29.9K. The largest seller was Morgan Stanley, cutting an estimated $78.8K.
- 16 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2014, down from 18 in Q1 2014.
- Funds reported $2.01M of Acer Therapeutics Inc stock for Q2 2014, down 13% quarter-over-quarter.
- 2 funds opened new Acer Therapeutics Inc positions in Q2 2014 and 4 closed out, a net change of -2 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2014 was Shepherd Kaplan Krochuk, an estimated $29.9K added.
- The largest Acer Therapeutics Inc seller in Q2 2014 was Morgan Stanley, an estimated $78.8K sold.
Based on aggregated 13F filings for Q2 2014.